Neola Medical AB (publ) (STO:NEOLA)

Market Cap	67.50M -59.2%
Revenue (ttm)	8.28M -18.1%
Net Income	-11.02M
EPS	-0.14
Shares Out	77.95M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,332
Average Volume	39,840
Open	0.8480
Previous Close	0.8660
Day's Range	0.8480 - 0.8660
52-Week Range	0.6020 - 3.0400
Beta	1.24
RSI	48.67
Earnings Date	Feb 12, 2026

About Neola Medical AB

Neola Medical AB (publ), together with its subsidiary, Neola Medical, Inc., develops medical technology devices for non-invasive continuous monitoring of the lungs of preterm born infants in Sweden. It offers NEOLA, a neonatal intensive care medical device that enables continuous lung monitoring and real-time alerts of life-threatening complications using technology that measures lung volume changes and oxygen gas concentration. The company was formerly known as GPX Medical AB and changed its name to Neola Medical AB (publ) in June 2022. Neola ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2016
• Employees: 8
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: NEOLA

Financial Performance

In 2025, Neola Medical AB's revenue was 8.28 million, a decrease of -18.13% compared to the previous year's 10.12 million. Losses were -11.02 million, 9.52% more than in 2024.